Redox-Responsive Polymersomes as Smart Doxorubicin Delivery Systems
- PMID: 36015350
- PMCID: PMC9412847
- DOI: 10.3390/pharmaceutics14081724
Redox-Responsive Polymersomes as Smart Doxorubicin Delivery Systems
Abstract
Stimuli-responsive polymersomes have emerged as smart drug delivery systems for programmed release of highly cytotoxic anticancer agents such as doxorubicin hydrochloride (Dox·HCl). Recently, a biodegradable redox-responsive triblock copolymer (mPEG-PDH-mPEG) was synthesized with a central hydrophobic block containing disulfide linkages and two hydrophilic segments of poly(ethylene glycol) methyl ether. Taking advantage of the self-assembly of this amphiphilic copolymer in aqueous solution, in the present investigation we introduce a solvent-exchange method that simultaneously achieves polymersome formation and drug loading in phosphate buffer saline (10 mM, pH 7.4). Blank and drug-loaded polymersomes (5 and 10 wt.% feeding ratios) were prepared and characterized for morphology, particle size, surface charge, encapsulation efficiency and drug release behavior. Spherical vesicles of uniform size (120-190 nm) and negative zeta potentials were obtained. Dox·HCl was encapsulated into polymersomes with a remarkably high efficiency (up to 98 wt.%). In vitro drug release studies demonstrated a prolonged and diffusion-driven release at physiological conditions (~34% after 48 h). Cleavage of the disulfide bonds in the presence of 50 mM glutathione (GSH) enhanced drug release (~77%) due to the contribution of the erosion mechanism. Therefore, the designed polymersomes are promising candidates for selective drug release in the reductive environment of cancer cells.
Keywords: doxorubicin hydrochloride; drug release kinetics; polymersome; redox-responsive; smart drug delivery systems; triblock copolymer mPEG–PDH–mPEG.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Albuquerque L.J.C., Sincari V., Jäger A., Kucka J., Humajova J., Pankrac J., Paral P., Heizer T., Janouškova O., Davidovich I., et al. pH-Responsive Polymersome-Mediated Delivery of Doxorubicin into Tumor Sites Enhances the Therapeutic Efficacy and Reduces Cardiotoxic Effects. J. Control. Release. 2021;332:529–538. doi: 10.1016/j.jconrel.2021.03.013. - DOI - PubMed
-
- Yassin M.A., Appelhans D., Wiedemuth R., Formanek P., Boye S., Lederer A., Temme A., Voit B. Overcoming Concealment Effects of Targeting Moieties in the PEG Corona: Controlled Permeable Polymersomes Decorated with Folate-Antennae for Selective Targeting of Tumor Cells. Small. 2015;11:1580–1591. doi: 10.1002/smll.201402581. - DOI - PubMed
-
- Zhao L., Zhang X., Liu X., Li J., Luan Y. pH-Responsive Poly(Ethylene Glycol)-Poly(ϵ-Caprolactone)-Poly(Glutamic Acid) Polymersome as an Efficient Doxorubicin Carrier for Cancer Therapy. Polym. Int. 2017;66:1579–1586. doi: 10.1002/pi.5416. - DOI
-
- Zhu D., Wu S., Hu C., Chen Z., Wang H., Fan F., Qin Y., Wang C., Sun H., Leng X., et al. Folate-Targeted Polymersomes Loaded with Both Paclitaxel and Doxorubicin for the Combination Chemotherapy of Hepatocellular Carcinoma. Acta Biomater. 2017;58:399–412. doi: 10.1016/j.actbio.2017.06.017. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
